24 studies found for:    "Bacterial Infections" | Japan
Show Display Options
Rank Status Study
1 Completed
Has Results
Study of a Single Dose of SP093 Typhoid Vi Polysaccharide Vaccine in Japanese Subjects
Conditions: Salmonella Infections;   Typhoid Fever;   Bacterial Infections
Intervention: Biological: Typhoid Vi polysaccharide
2 Completed
Has Results
Study of SP306 Given Intramuscularly Compared to DT BIK® Given Subcutaneously in Japanese Adolescents 11 - 12 Years Old
Conditions: Tetanus;   Diphtheria;   Pertussis
Interventions: Biological: Tdap: Tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine adsorbed;   Biological: Diphtheria and Tetanus toxoids adsorbed
3 Recruiting DTaP-IPV/Hib Vaccine Primary & Booster Vaccinations Versus Co-administration of DTaP-IPV and Hib Vaccine in Japanese Infants
Conditions: Tetanus;   Diphtheria;   Pertussis;   Poliomyelitis;   Bacterial Meningitis
Interventions: Biological: DTaP-IPV/Hib Combined vaccine;   Biological: DTaP-IPV vaccine and Hib vaccine
4 Completed Study of BK1301 (DTaP Vaccine) as a Booster in Adolescents
Conditions: Diphtheria;   Tetanus;   Pertussis
Interventions: Biological: Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed (DTaP vaccine, BK1301);   Biological: Adsorbed Diphtheria-Tetanus Combined Toxoid (DT toxoid)
5 Recruiting Safety and Efficacy of BAY1192631 in Japanese Patients With Methicillin-resistant Staphylococcus Aureus (MRSA) Infections
Condition: Skin Diseases, Infectious
Interventions: Drug: Tedizolid(BAY1192631);   Drug: Linezolid
6 Completed Efficacy of TAK-438, Amoxicillin and Clarithromycin in the First Line Eradication of H. Pylori
Condition: H. Pylori Infection
Interventions: Drug: TAK-438;   Drug: Lansoprazole;   Drug: Amoxicillin;   Drug: Clarithromycin
7 Completed Special Investigation of Clarith/Klaricid in Patients With Non-tuberculous Mycobacterial Pulmonary Infections
Condition: Mycobacterium Infections, Atypical
8 Completed
Has Results
Study of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (ADACEL®) as a Booster in Adolescents
Conditions: Pertussis;   Tetanus;   Diphtheria
Intervention: Biological: (ADACEL®): Tetanus, Reduced Diphtheria Toxoid and Acellular Pertussis
9 Completed
Has Results
Study of a Single Dose of Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine (SP284) in Japanese Subjects
Conditions: Meningitis;   Meningococcal Meningitis;   Meningococcal Infections
Intervention: Biological: Meningococcal polysaccharide diphtheria toxoid conjugate
10 Completed Randomized Trial for Pharmacogenomics-based Tuberculosis Therapy (RT-PGTT)
Condition: Pulmonary Tuberculosis
Interventions: Drug: Isoniazid;   Drug: isoniazed
11 Recruiting SA4Ag Safety, Tolerability, and Immunogenicity Study in Japanese Adults
Condition: Staphylococcal Infections
Interventions: Biological: Staphylococcus aureus 4-antigen vaccine;   Biological: Placebo
12 Recruiting An Exploratory Study of TMC207 in Japanese Participants With Pulmonary Multi-Drug Resistant Tuberculosis (MDR-TB)
Condition: Pulmonary Multi-Drug Resistant Tuberculosis (MDR-TB)
Interventions: Drug: TMC207 (bedaquiline);   Drug: Background Regimen (BR)
13 Completed A Placebo-controlled, Phase 2 Trial to Evaluate OPC 67683 in Patients With Pulmonary Sputum Culture-positive, Multidrug-resistant Tuberculosis (TB)
Conditions: Tuberculosis, Pulmonary;   Tuberculosis, Multidrug Resistant;   Extensively Drug-Resistant Tuberculosis
Interventions: Drug: OPC-67683;   Drug: Placebo
14 Completed A Phase III Study to Evaluate the Safety, Efficacy and Pharmacokinetics/Pharmacodynamics of BAYQ3939 in Patients With Bacterial Pneumonia
Condition: Pneumonia
Intervention: Drug: Ciprofloxacin (Cipro, BAYQ3939)
15 Completed
Has Results
The Study of Unasyn-S 12g/Day for Community Acquired Pneumonia (CAP)
Condition: Pneumonia, Bacterial
Intervention: Drug: ampicillin sodium/sulbactam sodium
16 Recruiting Inhaled Amikacin Solution (BAY 41-6551) as Adjunctive Therapy in the Treatment of Gram-Negative Pneumonia
Condition: Pneumonia, Bacterial
Interventions: Drug: Amikacin Inhalation Solution (BAY41-6551);   Drug: Aerosolized Placebo
17 Recruiting A Clinical Trial to Assess Three Different Doses of OPS-2071 in Patients With Bacterial Enteritis
Condition: Bacterial Enteritis
Intervention: Drug: OPS-2071  tablet
18 Recruiting Study to Evaluate Efficacy of LAI When Added to Multi-drug Regimen Compared to Multi-drug Regimen Alone
Condition: Mycobacterium Infections, Nontuberculous
Intervention: Drug: Liposomal Amikacin for Inhalation
19 Unknown  Seroepidemiological Study of Pertussis and Other Infectious Diseases
Condition: Pertussis Infection
20 Completed Phase III Clinical Trial of NPB-01 in Patients With Stevens-Johnson Syndrome/ Toxic Epidermal Necrolysis Unresponsive to Corticosteroids.
Conditions: Stevens-Johnson Syndrome;   Toxic Epidermal Necrolysis
Intervention: Drug: Intravenous immunoglobulin

   Previous Page Studies Shown (1-20) Next Page (21-24) Show next page of results    Last Page
Indicates status has not been verified in more than two years